Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Combined whole-brain MRI to predict recovery after cardiac arrest

Official title: Use of Brain Structural and Functional Connectomes for the Prediction of Neurological Recovery in Coma Patients After Cardiac Arrest

Run by University Hospital, Toulouse · NCT06617377 · Data updated 2026-11-12

This study tests whether personalized whole-brain MRI connectivity maps can better predict six-month neurological recovery in adults who remain unconscious after cardiac arrest compared with standard predictors.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment263 (estimated)
SponsorUniversity Hospital, Toulouse
Academic / other
Locations1 site (Toulouse)
StatusRecruiting
StartedMarch 16, 2026
Main results expectedSeptember 2029
Study endsSeptember 2029
Registry record updatedJune 29, 2026
Trial IDNCT06617377 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 years or older who remain comatose (GCS ≤ 8, motor ≤ 2) after resuscitation from cardiac arrest, after at least 72 hours of sedation withdrawal in normothermia, with legal representative consent.

Probably not a fit

Patients who do not show distinctive connectivity patterns or who meet exclusion criteria may not benefit from the MRI-based predictions.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Researchers will collect advanced structural and functional MRI data (including contrast-enhanced scans) from adults who remain unconscious 72 hours after cardiac arrest, and compare a connectome-based predictive model with traditional predictors such as clinical exams, electrophysiology, serum biomarkers, and standard imaging. The goal is to see if the MRI-derived brain network information can improve accuracy in predicting poor or favorable outcomes at 6 months. The study uses a standardized imaging protocol during normothermia and after sedation withdrawal, alongside established predictors. It is led by University Hospital, Toulouse, and aims to reduce misclassification related to self-fulfilling prophecies through strict timing and criteria. The approach builds on prior work suggesting that individualized brain connectivity reflects consciousness recovery potential.

Why it matters

Potential benefit: If successful, this approach could provide more accurate forecasts of recovery, guiding decision-making and care plans after cardiac arrest.

How similar studies have gone: Previous exploratory MRI studies suggested potential predictive value, but results require validation in a prospective, standardized protocol.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adult patients (male or female ≥ 18 years).
* Coma, as indicated by a Glasgow Coma Scale (GCS) ≤ 8 (motor score ≤ 2) immediately after CA resuscitation and before sedation onset.
* Persisting unconsciousness, defined as the inability to obey verbal commands, after at least 72 hours from complete withdrawal of sedation in normothermia conditions.
* Written informed consent from patient's legal representative.
* Affiliation or beneficiary to the French social security system.

Exclusion Criteria:

* Brain death.
* Coma explained by other cause than CA.
* Likely poor neurological outcome based on early predictors, following ERC-ESCIM 2021 recommendations. In a comatose patient with GCS motor score ≤ 3 at ≥ 72 h from ROSC, in the absence of confounders, the identification of at least two of the following: bilaterally absent pupillary light and corneal reflexes at ≥ 72h, bilaterally absent N20 SSEP ≥ 24h; neuron-specific enolase (NSE) \> 60 μg/l at 48h and/or 72h, status myoclonus ≤72h.
* Decision of WLST previous to patient recruitment, based on early predictors of poor neurological outcome, age, co-morbidity, general organ function and patient's preferences.
* Life expectancy shorter than 6 months based on pre-morbid conditions.
* Former neurological functional disability (mRS \> 2 before CA).
* MRI contraindication: medical material not MRI compatible, claustrophobia
* Known hypersensitivity to gadoteric acid, meglumin or any drug containing gadolinium
* Severe kidney failure defined as a KDIGO score \> 3 (glomerular filtration rate \< 30 ml/min/1.73 m2 or renal replacement therapy).
* Hemodynamic shock or severe respiratory failure precluding patient's transport and MRI scanning.
* Pregnancy or nursing woman.
* Patient under juridical protection.

Where it's running

  • UHToulouse
    Toulouse, France
    Recruiting

Study contacts

  • Principal investigator: Stein SILVA, MD PhD — University Hospital of Toulouse
  • Study coordinator: Stein SILVA, MD PhD
  • Email: silva.s@chu-toulouse.fr
  • Phone: 0561772288

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.